US 11564930
RIP1 inhibitory compounds and methods for making and using the same
granted A61KA61K31/553A61P
Quick answer
US patent 11564930 (RIP1 inhibitory compounds and methods for making and using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K31/553, A61P, A61P37/00